-+ 0.00%
-+ 0.00%
-+ 0.00%

Orbis Medicines Appoints Joanne Smith-Farrell as CEO

PUBT·10/27/2026 12:47:16
Listen to the news
Orbis Medicines Appoints Joanne Smith-Farrell as CEO
  • Orbis Medicines appointed Joanne Smith-Farrell as CEO to advance its AI-driven oral macrocycle platform and pipeline.
  • Co-founder Morten Graugaard moves from CEO to chief business officer, focusing on business development and strategic partnerships.
  • Smith-Farrell will oversee wholly owned immunology and inflammation programs, alongside a Novo Nordisk cardiometabolic collaboration valued at up to $1.4 billion.
  • She previously led Be Biopharma’s transition from a platform-focused business to a clinical-stage company with multiple programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forbion Capital Partners Management Services BV published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.